Inclusion Criteria:
Main Inclusion Criteria: 1) Male or female patients aged > 20 years; 2) Patients who have already been selected and approved under the Taiwan National Health Insurance Program to receive 24 weeks of etanercept for rheumatoid arthritis. Main
Exclusion Criteria:
Exclusion Criteria: None
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00888576?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
